Study of Chicory per oral administration effect in decreasing serum Ferritin level in major and intermediate beta thalassemia patient.
Not Applicable
- Conditions
- Major Thalassemia.Beta thalassaemia
- Registration Number
- IRCT2016112514333N61
- Lead Sponsor
- Vice chancellor for research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with thalassemia major; Patients with serum ferritin between 1000 and 3000.
Exclusion criteria: Patients with heart failure, hypertension and diabetes; Patients who have more than 3,000 ferritin in routine check
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum ferritin levels. Timepoint: Baseline, two months after the start of treatment and two months after the end of treatment. Method of measurement: Based on lab.
- Secondary Outcome Measures
Name Time Method